A proteomic and phosphoproteomic landscape of KRAS mutant cancers identifies combination therapies

1. Download : Download high-res image (203KB)
2. Download : Download full-size image

     

Ginsenoside Rg1 protects H9c2 cells against nutritional stress-induced injury via aldolase /AMPK/PINK1 signalling

Insufficient nutrients supply will greatly affect the function of cardiac myocytes. The adaptive responses of cardiac myocytes to nutritional stress are not fully known. Ginsenoside Rg1 is one of the most pharmacologically active components in Panax Ginseng and possesses protective effects on cardiomyocyte. Here, we investigate the effects of ginsenoside Rg1 on H9c2 cells which were subjected to nutritional stress. Nutritional stress-induced by glucose deprivation strongly induced cell death and this response was inhibited by ginsenoside Rg1. Importantly, glucose deprivation decreased intracellular ATP levels and mitochondrial membrane potential. Ginsenoside Rg1 rescued ATP levels and mitochondrial membrane potential in nutrient-starved cells. For molecular mechanisms, ginsenoside Rg1 increased the expressions of PTEN-induced kinase 1 (PINK1) and p-AMPK in glucose deprivation treated H9c2 cells. Reducing the expression of aldolase in H9c2 cells inhibited ginsenoside Rg1′s actions on PINK1 and p-AMPK. Further, the nutritional stress mice were used to verify the mechanisms obtained in vitro. Ginsenoside Rg1 increased the expressions of aldolase, p-AMPK, and PINK1 in starved mice heart. Taken together, our results reveal that ginsenoside Rg1 limits nutritional stress-induced H9c2 cells injury by regulating the aldolase /AMP-activated protein kinase/PINK1 pathway.     

Ligh- and electron-microscopic immunocytochemistry of somatotropes in the anterior pituitary gland of European ferret,Mustela putorius furo

Light-microscopic immunocytochemistry of ferret anterior pituitary revealed the localization of somatotropes in the pars distalis, but no immunoreactive cells were detected in the pars tuberalis. Ultrastructural studies by superimposition immunocytochemistry and immuno-electron microscopy, clucidated the morphological heterogeneity of these somatotropic cells. They were classified into 2 subtypes on the basis of size of the secretory granules. Type-I cells with small granules (mean diameter, 192 nm), were considered to be the immature somatotrop, while Type-II cells, with comparatively larger secretory granules (mean diameter, 257 nm), were considered to be the matured form of Type-I cells and the typical somatotropic cell-type, and were much more predominant than the Type-I cells. The fact that Type-II cells had a distinct Golgi zone and many mitochondria, while in Type-I cells the intracellular organelles were generally less developed, supports this suggestion. In addition to these two extreme subtypes, several intermediate forms were also encountered that may represent different transitional phases during the conversion of Type I to Type II. Protein A-gold immuno-electron microscopy illustrated the specific localization of growth hormone over the granules, with no labelling over any other cytoplasmic organelles of the 2 somatotrope subtypes.     

Translating Cancer Molecular Variability into Personalized Information Using Bulk and Single Cell Approaches

Cancer research is striving toward new frontiers of assigning the correct personalized drug(s) to a given patient. However, extensive tumor heterogeneity poses a major obstacle. Tumors of the same type often respond differently to therapy, due to patient‐specific molecular aberrations and/or untargeted tumor subpopulations. It is frequently not possible to determine a priori which patients will respond to a certain therapy or how an efficient patient‐specific combined therapy should be designed. Large‐scale datasets have been growing at an accelerated pace and various technologies and analytical tools for single cell and bulk level analyses are being developed to extract significant individualized signals from such heterogeneous data. However, personalized therapies that dramatically alter the course of the disease remain scarce, and most tumors still respond poorly to medical care. In this review, the basic concepts of bulk and single cell approaches are discussed, as well as their emerging role in individualized designs of drug therapies, including the advantages and limitations of their applications in personalized medicine.     

虎杖象甲培植真菌营养特性及对菌丝附属物形成的影响

虎杖象甲培植共生真菌形成的共生体系是植菌昆虫菌业中的典型代表。共生真菌Penicillium herquei如何向虎杖象甲Euops chinensis提供营养尚未明确。本研究发现共生真菌P. herquei的菌丝表面存在大量瘤状凸起物及由凸起物衍生的附属丝等特化结构,该结构可能为虎杖象甲提供营养;对共生真菌的营养研究表明,共生真菌能高效利用山梨醇、蔗糖、海藻糖、葡萄糖等单糖或双糖,以及酪氨酸、甘氨酸、谷氨酰胺等昆虫非必须氨基酸,同时在高碳和最适碳源条件下有利于菌丝特化附属物的产生。研究结果不仅提供了植菌卷叶象甲菌业中共生真菌在营养方面的适应性进化证据,而且为进一步揭示共生真菌适应卷叶象甲的营养机制奠定了基础。     

没食子酸对美国白蛾幼虫营养效应及解毒酶活性的影响

美国白蛾是我国重大外来入侵害虫,寄主范围十分广泛。酚类物质是最广泛的植物次生代谢物之一,在植物抵御昆虫取食的化学防御中具有重要作用。本研究通过人工饲料添加没食子酸的方法,探究不同浓度的没食子酸对美国白蛾幼虫的营养效应及解毒酶和乙酰胆碱酯酶活性的影响。结果表明,各浓度(1.0%、1.5%、2.0%、2.5%、3.0%)没食子酸对美国白蛾4龄幼虫的近似消化率、食物利用率、相对取食量和相对生长率均具有显著影响(P<0.05),近似消化率和相对取食量不同程度下降,食物利用率和相对生长率则不同程度上升。不同浓度的没食子酸处理对美国白蛾幼虫的乙酰胆碱酯酶、羧酸酯酶、谷胱甘肽S-转移酶和细胞色素P450的活性均具有显著影响(P<0.05)。1.0%没食子酸作用时间不同,美国白蛾4龄幼虫的乙酰胆碱酯酶、羧酸酯酶、谷胱甘肽S-转移酶和细胞色素P450的活性差异显著(P<0.05)。没食子酸能够始终诱导细胞色素P450的活性,而羧酸酯酶的活性却受到抑制。不同浓度的没食子酸对乙酰胆碱酯酶作用总体上不明显,但较低浓度时(1.0%)对乙酰胆碱酯酶活性却随处理时间延长而抑制作用加强。较低浓度(1.0%~1.5%)的没食子酸对谷胱甘肽S-转移酶的活性有一定诱导作用,但随着没食子酸浓度提高谷胱甘肽S-转移酶的活性却受到一定程度的抑制。没食子酸能抑制美国白蛾幼虫的取食,并且对解毒酶和乙酰胆碱酯酶的活性表现出一定的时间效应和剂量效应,表明美国白蛾幼虫可能通过调节食物利用和解毒代谢等多种途径降低没食子酸的毒害作用,从而对含没食子酸的寄主植物产生适应。